Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that it has engaged The Ruth Group (TRG), based in New York City, to serve as the Company's investor relations and public relations counsel.

Mr. Weidong Yin, President and CEO of Sinovac, stated, given their strong and broad experience in the biotechnology and pharmaceutical sectors, their familiarity with the information needs of the investment and media communities, and their time zone availability, we anticipate that they will add value by Sinovac's communications program."

Carol Ruth, President and CEO of The Ruth Group, Inc. said, "We are pleased to add Sinovac to our quality base of healthcare clients for which we provide investor and public relations counsel and best-in-class program implementation."

Source:佚名